BB Biotech AG

BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. It invests in public equity markets worldwide, focusing primarily on companies involved in medications and diagnostics based on modern biotechnology. The fund uses fundamental analysis to build its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.